121 related articles for article (PubMed ID: 16846668)
1. Long-term soluble Abeta1-40 activates CaM kinase II in organotypic hippocampal cultures.
Tardito D; Gennarelli M; Musazzi L; Gesuete R; Chiarini S; Barbiero VS; Rydel RE; Racagni G; Popoli M
Neurobiol Aging; 2007 Sep; 28(9):1388-95. PubMed ID: 16846668
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
Zhao D; Watson JB; Xie CW
J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
[TBL] [Abstract][Full Text] [Related]
3. Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity.
Lin KF; Chang RC; Suen KC; So KF; Hugon J
Eur J Neurosci; 2004 Apr; 19(8):2047-55. PubMed ID: 15090032
[TBL] [Abstract][Full Text] [Related]
4. Calcium/calmodulin-dependent protein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats.
Toscano CD; O'Callaghan JP; Guilarte TR
Brain Res; 2005 May; 1044(1):51-8. PubMed ID: 15862789
[TBL] [Abstract][Full Text] [Related]
5. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.
Sáez ET; Pehar M; Vargas MR; Barbeito L; Maccioni RB
J Neurosci Res; 2006 Oct; 84(5):1098-106. PubMed ID: 16862561
[TBL] [Abstract][Full Text] [Related]
6. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
8. MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time.
Bell KA; O'Riordan KJ; Sweatt JD; Dineley KT
J Neurochem; 2004 Oct; 91(2):349-61. PubMed ID: 15447668
[TBL] [Abstract][Full Text] [Related]
9. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
Hu NW; Smith IM; Walsh DM; Rowan MJ
Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
[TBL] [Abstract][Full Text] [Related]
10. A beta 25-35 induces presynaptic changes in organotypic hippocampal slice cultures.
Suh EC; Jung YJ; Kim YA; Park EM; Lee KE
Neurotoxicology; 2008 Jul; 29(4):691-9. PubMed ID: 18502514
[TBL] [Abstract][Full Text] [Related]
11. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts.
Cavazzin C; Bonvicini C; Nocera A; Racchi M; Kasahara J; Tardito D; Gennarelli M; Govoni S; Racagni G; Popoli M
Neurobiol Aging; 2004 Oct; 25(9):1187-96. PubMed ID: 15312964
[TBL] [Abstract][Full Text] [Related]
12. Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampus.
Lengyel I; Voss K; Cammarota M; Bradshaw K; Brent V; Murphy KP; Giese KP; Rostas JA; Bliss TV
Eur J Neurosci; 2004 Dec; 20(11):3063-72. PubMed ID: 15579161
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta-protein potentiates tunicamycin-induced neuronal death in organotypic hippocampal slice cultures.
Imai T; Kosuge Y; Ishige K; Ito Y
Neuroscience; 2007 Jul; 147(3):639-51. PubMed ID: 17560726
[TBL] [Abstract][Full Text] [Related]
14. Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures.
Johansson S; Jämsä A; Vasänge M; Winblad B; Luthman J; Cowburn RF
Neuroreport; 2006 Jun; 17(9):907-11. PubMed ID: 16738486
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel BE; Henkins KM; Parfitt KD
Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
[TBL] [Abstract][Full Text] [Related]
16. S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
Wang HY; Bakshi K; Shen C; Frankfurt M; Trocmé-Thibierge C; Morain P
Biol Psychiatry; 2010 Mar; 67(6):522-30. PubMed ID: 19932469
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression.
Chambers CB; Sigurdsson EM; Hejna MJ; Lorens SA; Lee JM; Muma NA
Exp Neurol; 2000 Mar; 162(1):158-70. PubMed ID: 10716896
[TBL] [Abstract][Full Text] [Related]
18. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid.
Minogue AM; Lynch AM; Loane DJ; Herron CE; Lynch MA
J Neurochem; 2007 Nov; 103(3):914-26. PubMed ID: 17711425
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL
Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
Matos M; Augusto E; Oliveira CR; Agostinho P
Neuroscience; 2008 Oct; 156(4):898-910. PubMed ID: 18790019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
